Phase III Trial to Investigate Efficacy and Safety of Vilobelimab in Ulcerative Pyoderma Gangrenosum
Stopped early · Phase 3 · Has a placebo group
Conditions studied: Pyoderma Gangrenosum
In brief
A randomized, double-blind, placebo-controlled, multicenter, adaptive phase III trial to investigate efficacy and safety of vilobelimab in the treatment of ulcerative pyoderma gangrenosum
Key facts
- Study ID
- NCT05964413
- Run by
- InflaRx GmbH
- People needed
- 54
- Starts
- 2023-11-01
- Expected to finish
- 2025-07-11
- Last updated by the study team
- 2025-11-04
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Aby´s New Generation Research, Inc — Hialeah, Florida, United States
- Dermatology/University of Miami Hospital — Miami, Florida, United States
- University of Central Florida College of Medicine — Orlando, Florida, United States
- ForCare Clinical Research — Tampa, Florida, United States
- Advanced Medical Research, PC — Sandy Springs, Georgia, United States
- Brigham and Women´s Hospital — Boston, Massachusetts, United States
- University of North Carolina at Chapel Hill Department of Dermatology — Chapel Hill, North Carolina, United States
- Ohio State University Wexner Medical Cente OSU Dermatology West — Columbus, Ohio, United States
- Apex Clinical Research Center — Mayfield Heights, Ohio, United States
- Oregon Health and Science University — Portland, Oregon, United States
- University of Pennsylvania — Philadelphia, Pennsylvania, United States
- The University of Texas Health Science Center at Houston — Bellaire, Texas, United States
- Premier Specialists — Kogarah, NewSouth Wales, Australia
- The Alfred Hospital, Melbourne — Melbourne, Victoria, Australia
- Veracity Clinical Research Pty Ltd as trustee for the MLS Trust — Brisbane, Australia
- Liverpool Hospital — Sydney, Australia
- Hôpitaux Universitaires de Bruxelles — Anderlecht, Belgium
- Cliniques Universitaires Saint-Luc — Brussels, Belgium
- CHU Toulouse Hospital Larrey — Toulouse, Occitanie, France
- Hospital Edouard Herriot — Lyon, France
- CHU de Nantes - Clinique dermatologique — Nantes, France
- Saint Louis Hospital — Paris, France
- Universitätshautklinik Tübingen — Tübingen, Baden Würrtemberg, Germany
- Berge Hautklinik — Erlangen, Bavaria, Germany
- Universitätsklinikum Heidelberg — Heidelberg, Bavaria, Germany
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.